狗过敏原和内毒素对肺功能和喘的保护作用
Makiko Nanishi1, Myrtha E Reyna2, Marija Pajdakovska1
1Division of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children & Research Institute, Toronto, Ontario, Canada.
The Journal of allergy and clinical immunology
|February 25, 2026
概括
婴儿期早期暴露于高水平的狗过敏原 (Can f1) 与更好的肺功能有关,并在5岁时降低了喘风险. 这种保护作用在具有较低肺功能遗传倾向分数的儿童中更为明显.
科学领域:
- 环境健康 环境健康
- 儿科过敏 儿科过敏
- 遗传学 遗传学 是一个
背景情况:
- 儿童喘涉及复杂的基因环境相互作用,特别是与过敏原.
- 以前关于过敏原暴露和喘风险的研究已经产生了不一致的结果.
研究的目的:
- 调查婴儿期室内过敏原暴露与5岁时喘发育和肺功能之间的纵向关联.
- 探索遗传因素在修改这些关系中的作用.
主要方法:
- 对3个月大的婴儿的尘埃样本进行Can f1 (狗过敏原),Fel d1 (猫过敏原) 和内毒素的分析.
- 在5岁时评估喘诊断和螺旋计.
- 使用肺功能多基因分数 (PGSs) 检查基因环境相互作用.
主要成果:
- 更高的Can f1暴露与喘风险显著降低相关 (OR0.52).
- 暴露在高Can f1的儿童的FEV1z分数显著改善 (β=0.23),无论喘状况如何.
- 在Can f1暴露和肺功能PGS之间观察到显著的基因环境相互作用.
结论:
- 在一般人群中,早期暴露于高CANf1水平与改善肺功能和预防儿童喘有关.
- 高CANf1暴露可能特别调节遗传敏感个体的肺功能 (那些低PGS).
相关概念视频
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Antiasthma Drugs: Leukotriene Modifiers
2.0K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
Allergic Reactions
32.7K
Overview
32.7K


